October 23, 2017 2:46 AM ET


Company Overview of Xenothera SAS

Company Overview

Xenothera SAS, a biotechnology company, develops a platform with embedded technology that renovates immunological treatments. It develops new therapeutic modes in various domains from immunomodulation to infectious diseases. The company’s therapeutic modes are based on animal genetics and mastery of immunology processes. It renovates passive immunotherapy by marketing a new generation of hyperimmune polyclonal sera. Xenothera SAS was founded in 2014 and is based in Nantes, France.

1 rue Gaston Weil

Cedex 1

Nantes,  44035


Founded in 2014


33 7 70 21 377


33 7 43 50 228

Key Executives for Xenothera SAS

Chief Executive Officer
Chief Scientific Officer
Age: 73
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
Acticor Biotech SAS Europe
Ademtech SA Europe
Aelis Farma S.A.S. Europe
Aenitis Technologies SAS Europe
Alderys SAS Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Xenothera SAS, please visit www.xenothera.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.